Narrower radiation after brain tumor surgery aims to spare healthy tissue
NCT ID NCT07368283
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using a smaller radiation target area after glioblastoma surgery can control the tumor while causing fewer side effects. About 79 patients will receive limited-field radiotherapy plus standard chemotherapy. The main goals are to see how many patients are alive without tumor growth at 6 months and to measure serious brain damage from radiation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- limited-field radiotherapy plus temozolomide chemotherapy
- What this could lead to
- If successful, this approach could reduce long-term brain side effects from radiation while still controlling the tumor.
- What could go wrong
- This is a small, early-phase study with no control group, so results may not be definitive. The limited radiation field might also miss some cancer cells, increasing the risk of recurrence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA (GBM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Custom-Made vaccine train the immune system to fight brain cancer?
- Can a virus injected into brain tumors fight recurrence?
- Can adding lenvatinib to standard care outsmart a tough brain cancer?
- Can a pill reach the brain and fight tumors?
- Targeted radiation delivered directly to brain tumor cavity in new trial
- Oxygen-Enhanced MRI could sharpen radiotherapy for deadly brain cancers